Live Breaking News & Updates on Belinda Mandrell

Stay updated with breaking news from Belinda mandrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma


Date Time
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
(From left) First and corresponding author Monika Metzger, M.D., Departments of Oncology and Global Pediatric Medicine; co- senior author Matthew Krasin, M.D., Department of Radiation Oncology; and co-senior author Melissa Hudson, M.D., Cancer Survivorship Division director.
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieved excellent outcomes, reduced side effects, and allowed for reduced radiation exposures.
The study was the result of work by a multi-site consortium dedicated to pediatric Hodgkin-lymphoma. Collaborating institutions include St. Jude Children’s Research Hospital, Stanford University School of Medicine, Dana-Farber Cancer Institute, Massachusetts General Hospital, Maine Childr ....

United States , Dana Farber Cancer Institute , Belinda Mandrell , Susan Hiniker , Alison Friedmann , John Lucas Jr , Sandra Luna Fineman , Chen Li , Matthew Ehrhardt , Matthew Krasin , Monika Metzger , Nickhill Bhakta , Amy Billett , Melissa Hudson , Hodgkin Reed Sternberg , Zhaohua Lu , Barry Shulkin , Jamie Flerlage , Eric Larson , Nemours Alfredi Dupont , Torunn Yock , Sarah Donaldson , National Cancer Institute , Jude Children Research Hospital , Judecancer Survivorship Division , Stanford University School Of Medicine ,